The Cooper Companies, Inc (COO)
NASDAQ · Healthcare · Medical Instruments & Supplies
The Cooper Companies, Inc is a Healthcare company with a market capitalization of $13.85B and a trailing P/E ratio of 60.2.
5-Year Price History
Latest Annual Financials · FY ending October 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q2 2026 | June 4, 2026 | $0.00 | $1.10 | -100.0% |
| Q1 2026 | March 5, 2026 | $0.66 | $0.68 | -2.9% |
| Q4 2025 | December 4, 2025 | $0.43 | $0.77 | -44.2% |
| Q3 2025 | August 27, 2025 | $1.10 | $1.07 | +2.8% |
| Q2 2025 | May 29, 2025 | $0.96 | $0.93 | +3.2% |
| Q1 2025 | March 6, 2025 | $0.92 | $0.91 | +1.1% |
Other Medical Instruments & Supplies Stocks
Frequently Asked Questions
What is The Cooper Companies, Inc's market cap?
As of June 29, 2026, The Cooper Companies, Inc (COO) has a market capitalization of $13.85B.
What is The Cooper Companies, Inc's P/E ratio?
The Cooper Companies, Inc trades at a trailing price-to-earnings (P/E) ratio of 60.2. Its forward P/E is 15.2.
Does The Cooper Companies, Inc pay a dividend?
The Cooper Companies, Inc does not currently pay a dividend.
What sector is COO in?
The Cooper Companies, Inc is in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
What was The Cooper Companies, Inc's revenue?
In its latest reported fiscal year (ending October 31, 2025), The Cooper Companies, Inc reported revenue of $4.09B and net income of $374.90M.
Ask your own questions about COO
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.